GenMont Biotech Incorporation (TPE:3164)
16.10
+0.25 (1.58%)
Aug 26, 2026, 1:30 PM CST
-18.69% (1Y)
| Market Cap | 1.36B -20.1% |
| Revenue (ttm) | 382.11M -1.1% |
| Net Income | 69.17M +344.7% |
| EPS | 0.80 +344.5% |
| Shares Out | 86.01M |
| PE Ratio | 19.83 |
| Forward PE | n/a |
| Dividend | 0.80 (5.05%) |
| Ex-Dividend Date | Apr 8, 2026 |
| Volume | 31,412 |
| Open | 15.80 |
| Previous Close | 15.85 |
| Day's Range | 15.80 - 16.15 |
| 52-Week Range | 15.35 - 20.45 |
| Beta | 0.07 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Nov 11, 2026 |